The present study was designed to investigate the capacity of human vascular smooth muscle cells (SMCs) to produce a cytokine chemotactic for monocytes (monocyte chemotactic protein 
V ascular cells play an active role in hemostasis, inflammation, and immunity. The major cell types of the vascular wall, endothelial cells (ECs) and smooth muscle cells (SMCs), produce and respond to cytokine mediators of inflammation and immunity such as interleukin-1 (IL-1) (for a review, see Reference 1) . IL-1 and the functionally related cytokine, tumor necrosis factor (TNF), activate proinflammatory and prothrombotic functions of ECs. 1 The actions of these inflammatory cytokines on ECs favor leukocyte extravasation by inducing de novo or augmented expression of adhesion structures 2 " 4 and production of prostanoids, 56 platelet-SMCs are a major constituent of blood vessels (muscular arteries) and are involved in vascular diseases such as atherosclerosis and vasculitis. SMCs respond to and produce various cytokines. 1314 This study investigated the capacity of SMCs to express members of an emerging superfamily of inflammatory mediators involved in leukocyte recruitment, monocyte chemotactic protein (MCP) and IL-8 (also referred to as neutrophil activating protein-1, NAP-1; reviewed in . Members of this superfamily share four conserved cysteine residues and presumably share similar three-dimensional structures. IL-8, representative of a family of mediators having the first two conserved cysteines interrupted by an extra amino acid (cysteine-X-cysteine family), was identified as a chemotactic and activation signal for neutrophils. 19 -24 IL-8 also activates basophils, 25 lymphocytes, 26 and melanoma cells 27 but not monocytes. MCP (cysteine-cysteine family) was identified as a monocyte chemoattractant produced by tumor cells (tumor-derived chemotactic factor) and myeloid cell lines. 28 - 32 Valente et al 33 - 34 reported that baboon aortic SMCs produced a monocyte chemoattractant antigenically related to a tumor-derived chemoattractant. 35 Here, we show that on exposure to IL-1 and TNF, human vascular SMCs transcribe the MCP gene and express MCP mRNA and protein. Supernatants of activated SMCs contained appreciable levels of IL-8, as determined by enzyme-linked immunosorbent assay (ELISA), but had little chemotactic activity for neutrophils. Activated SMCs transcribed the IL-8 gene and accumulated specific mRNA. Monocyte recruitment characterizes the earliest stages of experimental atherosclerosis, and macrophages abound in regions of the advanced human atheroma. SMCs compose the bulk of blood vessels susceptible to atherosclerosis. The capacity of SMCs to express the gene for MCP may thus contribute to both the initiation and progression of atherosclerosis and other pathological processes that involve vascular or perivascular infiltration by mononuclear phagocytes.
Methods

Vascular Cells
Three separate human vascular SMC cultures were used in this study. One SMC culture (A617 from human femoral artery) was kindly donated by G. Gabbiani (University of Geneva School of Medicine, Geneva, Switzerland). The other two (Nos. 411 and 415) were SMCs isolated from outgrowths of explants of unused portions of human saphenous veins harvested for coronary artery bypass surgery as described previously. 36 The cells were maintained in Dulbecco's modified Eagle's medium (DMEM; GIBCO, Paisley, Scotland) that contained 5.5 mM glucose, 25 mM W-2-hydroxyethylpiperazine-W-2-ethanesulfonic acid (HEPES), and 10% fetal calf serum (FCS) (HyClone Laboratories, Logan, Utah). The morphology and growth pattern of the cells, as determined by phase-contrast microscopy and immunohistochemical reactivity with anti-smooth muscle actin antibody (courtesy of G. Gabbiani), were typical of cultured SMCs. Cultures were used within the 14th passage. After the cells became confluent, the SMCs were stimulated with 10 ng/ml IL-l/J, washed twice with phosphate-buffered saline (PBS), and incubated again for 20 hours with DMEM containing 0.2% bovine serum albumin (BSA; Sigma Chemical Co., St. Louis, Mo.), and the supernatants were collected for assessment of leukocyte chemotactic activity.
ECs (second to eighth passage) from human umbilical veins were cultured in Medium 199 (GIBCO) supplemented with 20% FCS (HyClone) and were used in the study as described in detail in previous reports.
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Reagents and Cytokines
Recombinant human IL-1/3 (specific activity, 10 37 The antibody was used as recently described for ECs. 11 A Sepharose-protein A-immobilized anti-MCP/JE microcolumn was prepared as described by Leonard and Skeel. 38 The SMC supernatant was passed through the column and then assayed for chemotactic activity for monocytes. Normal rabbit serum was used for the preparation of a control column. Actinomycin D and cycloheximide used in this study were purchased from Sigma.
Leukocyte Preparation
Human mononuclear cells were obtained from healthy volunteers by sedimentation of heparinized blood centrifuged at 400g for 20 minutes on FicollHypaque (Lymphoprep, Nyagaad, Oslo, Norway). The cells were washed, and after a differential count on a cytocentrifuge preparation, were adjusted to a concentration of lxlO 6 monocytes/ml PBS containing 0.2% BSA. To purify the neutrophils after FicollHypaque centrifugation, the pellet containing erythrocytes and neutrophils was resuspended in PBS and mixed with a commercially available dextran solution (Eufusin, STHOLL Farmaceutici, Modena, Italy) at a concentration of 3 ml Eufusin/ml blood cells. The neutrophil-rich supernatant obtained after 30 minutes of 4°C incubation was then centrifuged, and the cell pellet was mixed with cold distilled water for 30 seconds to lyse the residual erythrocytes. Cells were then washed twice and resuspended at 1.5xlO 6 /ml in Hanks' balanced salt solution (GIBCO) with 0.2% BSA. The final preparation contained greater than 95% neutrophils.
Enzyme-Linked Immunosorbent Assay for Interleukin-8
Immunoreactive IL-8 (NAP-1) was quantified by ELISA. In brief, mouse monoclonal anti-NAP-1 antibodies were used for coating the wells of microtiter plates (for 16 hours at 4°C). After four washings (PBS [pH 7.5], containing 0.05% Tween-20), human recombinant NAP-1 (Sandoz, Basel, Switzerland) at a concentration of 0.02-10 ng/ml or unknown samples were added to precoated wells and incubated for 2 hours at 37°C. After four washings, goat anti-NAP-1 alkaline phosphatase conjugate was added, and the plates were incubated for another 2 hours at 37°C. After addition of /j-nitrophenyl phosphate and further incubation, the enzymatic reac- tion was terminated by addition of 2N NaOH. Absorbance was read at 405 nm. The detection limit of this method is about 3.0 pg/ml.
FIGURE 1. Line plots showing induction ofmonocyte and neutrophil chemotactic activity in vascular smooth muscle cells (SMCs) by interleukin-1 (IL-1). Vascular SMCs and endothelial cells (ECs) were cultured for 4 hours with 10 nglml IL-ip and then
Chemotaxis Assay
Leukocyte chemotaxis was assessed by a microchamber technique. 39 Twenty-five-microliter supernatants diluted in PBS (for monocytes) or in Hanks' balanced salt solution (for neutrophils) were placed in the lower compartment of the microchamber, and 50 fil cell suspension was seeded in the upper compartment. The two compartments were separated by a polycarbonate filter (5-^m pore size, Neuroprobe, Cabin John, Md.; polyvinylpyrrolidone-free for neutrophil migration). The chambers were incubated at 37°C for 90 minutes (for monocytes) or 120 minutes (for neutrophils); at the end of incubation, filters were removed, fixed, and stained with Diff-Quik (Harleco, Gibbstown, N.J.), and five oil-immersion fields were counted after the samples were coded. Each experiment usedN-formyl-methyl-leucyl-phenylalanine (Sigma) as a reference chemoattractant at the optimal concentration of 10 nM. The statistical significance of migration toward stimulus versus that toward medium control was assessed by Dunnet's test. One unit per milliliter activity was defined as the reciprocal of the dilution at which 50% of maximal chemotactic response was obtained compared with that obtained toward 7V-formyl-methyl-leucyl-phenylalanine.
Northern Blot Analysis
Northern blot analysis was performed according to standard procedures. 40 Total RNA was isolated by the guanidine isothiocyanate method. 41 Fifteen micrograms total RNA was analyzed by electrophoresis through 1% agarose formaldehyde gels, followed by Northern blot transfer to Gene Screen Plus membranes (New England Nuclear, Boston, Mass.) The plasmids containing the full-length cDNA human MCP probe (0.672-kb Pst 1-Pst I fragment 42 ) and the human IL-8 cDNA clone (0.3-kb Pst I-EcoRl fragment 21 ) were nick translated with a-phosphorus-32-labeled deoxycytidine triphosphate (5,000 Ci/mmol; Amersham, Buckinghamshire, UK). Membranes were pretreated and hybridized in 50% formamide 
Nuclear Runoff
Nuclear runoff experiments were performed essentially as described 43 
Quantification of Autoradiography
The optical density of the autoradiographic bands integrated for the band area was evaluated by a digitized image analyzer (RAS 3000, Loats System, Amersham). The "relative induction" was determined by dividing the densitometric quantification of the induced bands by the densitometric quantification of the unstimulated band. tivity, as assessed by induction of monocyte migration across polycarbonate filters. Figure 1 shows data from one experiment (representative of five performed), in which SMCs were exposed to 10 ng/ml IL-1/3; the supernatant was obtained after 20 hours. Figure 2 presents data expressed as units per milliliter of chemotactic activity. In this series of five experiments, IL-1-stimulated SMCs released 53 ±14 units/ml (mean±SEM; range, 27-100 units/ml) monocyte chemotactic activity compared with 3±1 units/ml (range, 0.5-7 units/ml) from unstimulated SMCs (/J<0.01). Amounts of MCP released by activated SMCs were comparable to those produced by human umbilical vein ECs stimulated under the same conditions (References 10 and 12 and Figures 1 and  2 ). Several lines of evidence indicate that the IL-1 molecule per se was not responsible for monocyte chemotaxis. When SMCs were exposed to 10 ng/ml IL-1/3 for 4 hours, washed, and then incubated with serum-free medium for 20 hours, they released high levels of MCP. Moreover, in agreement with previous reports, 101219 IL-1 tested over a wide range of concentrations and experimental conditions affected neither leukocyte migration nor the chemotactic activity of reference chemoattractants (data not shown). Another series of experiments examined the kinetics of MCP activity and the effect of different IL-1 doses. The maximum induction of MCP activity in SMCs by IL-1 occurred after 4 hours' incubation, and the optimal doses for the stimulation ranged between 1 and 10 ng/ml in different experiments (data not shown).
Results
On
To identify MCP as the mediator responsible for SMC-produced chemotactic activity, we used a specific antiserum raised against MCP/JE. 11 Absorption with immobilized anti-MCP/JE antibodies reduced SMC chemotactic activity for monocytes by 70% (Figure 3 ). Nonimmune serum had no effect, and the antiserum alone did not affect the chemotactic activity of Af-formyl-methyl-leucyl-phenylalanine, excluding nonspecific effects.
By way of comparison, we examined IL-8 production by cytokine-stimulated SMCs by use of an ELISA and chemotaxis for neutrophils. As shown in Figure 4 , IL-1-stimulated SMCs released appreciable levels of IL-8 as determined by ELISA. In apparent contrast with these data, supernatants of IL-1-stimulated SMCs had little chemotactic activity for neutrophils (Figures 1  and 2) . The results shown in Figure 1 are representative of three separate vascular SMC lines tested over a period of 6 months. By way of comparison, Figure 1 also shows the release of chemoattractants by IL-1-stimulated umbilical vein ECs. As reported previously, 811 cytokine-activated ECs released both IL-8 and MCP. The MCP activity released by SMCs and ECs was comparable.
In an effort to define the molecular basis of MCP activity, we examined expression of cytokine mRNA transcripts in SMCs by Northern blot analysis. Unstimulated SMCs did not express appreciable levels of steady-state MCP and IL-8 transcripts ( Figure 5 ), Discussion These results demonstrate that SMCs, on stimulation with IL-1, produce high levels of MCP. MCP release induced by IL-1 in SMCs was associated with expression of specific mRNA transcripts. Nuclear runoff experiments revealed that IL-1 transcriptionally activates the MCP gene. Previous studies had already shown that baboon aortic SMCs in the absence of deliberate stimulation produce an 8-12-kd monocyte chemoattractant, 3334 and more recently this has been shown to be antigenically cross-reactive with a chemoattractant produced by tumor cell lines. 35 The results reported here which identify MCP as a product released by SMC on IL-1 activation, provide a molecular basis for these observations. It has been previously reported 9 " 12 and confirmed here that ECs express MCP (and IL-8) both at the mRNA and at the protein levels. With the caveat that we studied vascular SMCs and ECs from different blood vessels and that a quantitative comparison was beyond the scope of the present study, the results obtained indicate comparable levels of production of MCP for ECs and SMCs.
In an effort to comprehensively characterize the production of chemotactic cytokines by SMCs, we studied the expression and release of IL-8. Cytokinestimulated SMCs transcribed the IL-8 gene and expressed high levels of steady-state IL-8 mRNA transcripts. As expected on the basis of these results, IL-8 was detected in the supernatants of activated SMCs by ELISA, but levels of neutrophil chemotactic activity were negligible. The coexistence of an inhibitor or the production of a version of IL-8 with lower specific activity could account for this apparent discrepancy. In preliminary experiments we failed to identify inhibitory activity for neutrophil chemotaxis in SMC supernatants. The occurrence of IL-8 molecules with different Af-termini has been documented (e.g., for review, see Reference 44) , and a 77 amino acid version of IL-8 has been reported to be 10 times less active than the "conventional" 73 amino acid form. 45 Elucidation of this point, which was beyond the main objective of the present study, will require identification of the IL-8 form produced by SMCs.
Renal mesangial cells share several properties with SMCs. 46 In a recent analysis of cytokine production by human renal mesangial cells, we found a pattern of chemotactic cytokine release similar to that reported here for vascular SMCs, that is, release of MCP in the absence of appreciable levels of neutrophil chemotactic activity (C. Zoja et al, unpublished observations); gene transcription and steady-state mRNA transcripts of both MCP and IL-8 were detected in stimulated human mesangial cells. MCP production by SMC-related mesangial cells may play an important role in kidney pathology.
SMCs are a major constituent of blood vessels. Cells of the monocyte-macrophage lineage have been identified in and around vessel walls affected by vasculitis. 47 Monocyte extravasation represents an early event in atherosclerosis. 48 Minimally modified low density lipoproteins, which may play an important role in atherosclerosis, induce expression of colony-stimulating factors in vascular endothelium. 49 These modified lipoproteins also induce release of monocyte chemotactic activity by rabbit endothelium. 50 While this report was being submitted, MCP expression was shown to underlie the latter observation. 51 In this context, it is of interest that Taubman et al 52 recently reported that platelet-derived growth factor and angiotensin II have opposing influences on JE mRNA levels in SMCs, causing increased and decreased expression, respectively. The capacity of SMCs to produce a cytokine (MCP) that recruits and activates circulating mononuclear phagocytes may be of considerable importance in the pathogenesis of vascular diseases characterized by monocyte infiltration of the vessel wall.
